Actively Recruiting
Real-World Treatment Study of Koselugo (Selumetinib)
Led by AstraZeneca · Updated on 2026-04-30
200
Participants Needed
12
Research Sites
380 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
As part of a post-approval commitment, the Korean health authority requests a study to characterize safety and effectiveness in patients treated with Koselugo (Selumetinib), an oral selective inhibitor of MAPK kinase (MEK) 1 and 2, by physicians in routine clinical practice settings. This study is designed to assess the known safety profile or identify previously unsuspected adverse reactions and evaluate the effectiveness of Koselugo under conditions of routine daily medical practice in Korea. This study will provide information on the Korean patient population that is treated with the study drug.
CONDITIONS
Official Title
Real-World Treatment Study of Koselugo (Selumetinib)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated with Koselugo (Selumetinib) under the approved label in South Korea
- Provision of signed and dated written informed consent by the patient or legally acceptable representative
You will not qualify if you...
- Patients not treated with Koselugo (Selumetinib) under the approved label in South Korea
- Lack of signed and dated written informed consent by the patient or legally acceptable representative
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
Research Site
Busan, South Korea
Actively Recruiting
2
Research Site
Chungcheongbuk-do, South Korea
Actively Recruiting
3
Research Site
Daejeon, South Korea
Actively Recruiting
4
Research Site
Gyeonggi-do, South Korea
Actively Recruiting
5
Research Site
Incheon, South Korea
Actively Recruiting
6
Research Site
Jeonnam, South Korea
Actively Recruiting
7
Research Site
Seoul, South Korea
Suspended
8
Research Site
Seoul, South Korea
Actively Recruiting
9
Research Site
Seoul, South Korea
Completed
10
Research Site
Seoul, South Korea
Not Yet Recruiting
11
Research Site
Wŏnju, South Korea
Actively Recruiting
12
Research Site
Yangsan, South Korea
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here